Enlivex Ltd. — Company profile
Healthcare · Biotechnology · Israel
Last price 2.54 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.16M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2. Enlivex Ltd. was formerly known as Enlivex Therapeutics Ltd. and changed its name to Enlivex Ltd. in February 2026. The company was founded in 2005 and is headquartered in Ness Ziona, Israel.
Details
| Name | Enlivex Ltd. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 34 |
| Founded | 2005 |
| Ipo Date | 1995-12-12 |
| Ceo | Oren Hershkovitz |
| Country | Israel |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | IL0011319527 |
| Cusip | M20156127 |
| Cik | 0001596812 |
| Sic | 6199 |
Key executives
| Name | Title |
|---|---|
| Dr. Oren Hershkovitz Ph.D. | Chief Executive Officer |
| Shai Novik M.B.A. | Executive Chairman |
| Prof. Dror Mevorach M.D. | Founder and Scientific Advisor |
| Shachar Shlosberger CPA | Chief Financial Officer |
| Dr. Veronique Amor-Baroukh | Chief Operating Officer |
| Sigal Arad | Director of Human Resources |
| Dr. Einat Galamidi M.D. | Chief Medical Officer |
Contact
| Address | 14 Einstein Street, Ness Ziona, 7403618, Israel |
| Phone | 972 2 620 8072 |
| Website | https://www.enlivex.com |